Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2025)

Sanara MedTech (SMTI) has disclosed Income from Non-Controlling Interests for 7 consecutive years, with -$955.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Income from Non-Controlling Interests rose 45.11% year-over-year to -$955.0, compared with a TTM value of -$190761.0 through Sep 2025, down 119.17%, and an annual FY2024 reading of -$247351.0, down 80.94% over the prior year.
  • Income from Non-Controlling Interests was -$955.0 for Q3 2025 at Sanara MedTech, up from -$4036.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $242000.0 in Q4 2022 and bottomed at -$185564.0 in Q4 2024.
  • Average Income from Non-Controlling Interests over 5 years is -$6104.6, with a median of -$25250.0 recorded in 2023.
  • Peak annual rise in Income from Non-Controlling Interests hit 5032.18% in 2021, while the deepest fall reached 809.07% in 2021.
  • Year by year, Income from Non-Controlling Interests stood at -$8277.0 in 2021, then soared by 3023.76% to $242000.0 in 2022, then crashed by 110.43% to -$25250.0 in 2023, then crashed by 634.91% to -$185564.0 in 2024, then skyrocketed by 99.49% to -$955.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for SMTI at -$955.0 in Q3 2025, -$4036.0 in Q2 2025, and -$206.0 in Q1 2025.